BIPINCHANDRA HIRISAVE KRISHNA: Open Payments
NPI 1386854651 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,699 in 74 payments from 16 companies in 2025. Trend: 2023 $202 · 2024 $1,121 · 2025 $1,699
Food & beverage: $1,699
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $422 |
| Janssen Pharmaceuticals, Inc | 13 | $395 |
| Axsome Therapeutics, Inc. | 9 | $236 |
| Corium, LLC | 6 | $130 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Lundbeck LLC | 4 | $109 |
| Supernus Pharmaceuticals, Inc. | 5 | $78 |
| ABBVIE INC. | 3 | $51 |
| Alkermes, Inc. | 2 | $47 |
| Noven Therapeutics, LLC | 1 | $22 |
Products named: CAPLYTA, Auvelity, INVEGA SUSTENNA, REXULTI, SPRAVATO, Azstarys, Qelbree, VRAYLAR.
Industry payments across GA — which companies pay providers there.
